A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
Hsp90 as a capacitor for morphological evolution
1998 • 2,261 citations
Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.
1994 • 1,426 citations
Hsp90 as a capacitor of phenotypic variation
2002 • 1,347 citations
Crystal Structure of an Hsp90–Geldanamycin Complex: Targeting of a Protein Chaperone by an Antitumor Agent
1997 • 1,345 citations
Identification and Structural Characterization of the ATP/ADP-Binding Site in the Hsp90 Molecular Chaperone
1997 • 1,235 citations
Modulation of Akt kinase activity by binding to Hsp90
2000 • 942 citations
ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone invivo
1998 • 709 citations
In Vivo Function of Hsp90 Is Dependent on ATP Binding and ATP Hydrolysis
1998 • 584 citations
Heat shock protein 90 as a molecular target for cancer therapeutics
2003 • 572 citations
Hsp90: Chaperoning signal transduction
2001 • 569 citations
The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin
1998 • 474 citations
Polyubiquitination and Proteasomal Degradation of the p185c-B-2 Receptor Protein-tyrosine Kinase Induced by Geldanamycin
1996 • 460 citations
Disruption of the Raf-1-Hsp90 Molecular Complex Results in Destabilization of Raf-1 and Loss of Raf-1-Ras Association
1995 • 454 citations
17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts.
2002 • 427 citations
Sensitivity of Mature ErbB2 to Geldanamycin Is Conferred by Its Kinase Domain and Is Mediated by the Chaperone Protein Hsp90
2001 • 354 citations
A 90,000-dalton binding protein common to both steroid receptors and the Rous sarcoma virus transforming protein, pp60v-src.
1985 • 304 citations
A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells
2001 • 282 citations
Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2
2002 • 269 citations
The Heat Shock Protein 90 Antagonist Geldanamycin Alters Chaperone Association with p210bcr-abl and v-src Proteins before Their Degradation by the Proteasome
2000 • 269 citations
The Assembly of Progesterone Receptor-hsp90 Complexes Using Purified Proteins
1998 • 239 citations
Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs
2002 • 236 citations
The Importance of ATP Binding and Hydrolysis by Hsp90 in Formation and Function of Protein Heterocomplexes
1999 • 224 citations
Geldanamycin-Induced Destabilization of Raf-1 Involves the Proteasome
1997 • 193 citations
Geldanamycin selectively destabilizes and conformationally alters mutated p53.
1995 • 185 citations
17AAG: low target binding affinity and potent cell activity--finding an explanation.
2003 • 151 citations
Expression and Roles of Heat Shock Proteins in Human Breast Cancer
1996 • 118 citations
Differential expression of heat shock proteins in pancreatic carcinoma.
1994 • 117 citations
Depletion of the erbB-2 gene product p185 by benzoquinoid ansamycins.
1994 • 115 citations
Auditing the pharmacological accounts for Hsp90 molecular chaperone inhibitors: unfolding the relationship between pharmacokinetics and pharmacodynamics.
2003 • 108 citations
Telomerase as a Target for Cancer Immunotherapy
2003 • 47 citations